APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acne Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acne Medicine Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchAcne Medicine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Acne Medicine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Acne Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acne Medicine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Acne Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Acne Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acne Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acne Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acne Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acne Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acne Medicine market include HUAPONT, Teva, Sine Pharma, Lion, Mylan, Sun Pharma, Mayne Pharma, GlaxoSmithKline and Galderma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Acne Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acne Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acne Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Acne Medicine market.

Acne Medicine Segment by Company

HUAPONT

Teva

Sine Pharma

Lion

Mylan

Sun Pharma

Mayne Pharma

GlaxoSmithKline

Galderma

Bausch Health

Almirall

Acne Medicine Segment by Type

OTC

Prescription Medicine

Acne Medicine Segment by Application

Topical

Oral

Acne Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Acne Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Acne Medicine key companies, revenue, market share, and recent developments.

3. To split the Acne Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Acne Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acne Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Acne Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acne Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acne Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acne Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acne Medicine industry.

Chapter 3: Detailed analysis of Acne Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Acne Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Acne Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acne Medicine Industry Trends Table 2. Acne Medicine Industry Drivers Table 3. Acne Medicine Industry Opportunities and Challenges Table 4. Acne Medicine Industry Restraints Table 5. Global Acne Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acne Medicine Revenue Share by Company (2021-2026) Table 7. Global Acne Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Acne Medicine Key Company Manufacturing Base & Headquarters Table 9. Global Acne Medicine Company, Product Type & Application Table 10. Global Acne Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Acne Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of OTC Table 15. Significant Companies of Prescription Medicine Table 16. Global Acne Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Acne Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Acne Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Acne Medicine Sales Value Share by Type (2021-2026) Table 20. Global Acne Medicine Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Topical Table 22. Significant Companies of Oral Table 23. Global Acne Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Acne Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Acne Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Acne Medicine Sales Value Share by Application (2021-2026) Table 27. Global Acne Medicine Sales Value Share by Application (2027-2032) Table 28. Global Acne Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Acne Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Acne Medicine Sales Value Share by Region (2021-2026) Table 31. Global Acne Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Acne Medicine Sales Value Share by Region (2027-2032) Table 33. Global Acne Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Acne Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Acne Medicine Sales Value Market Share by Country (2021-2026) Table 36. Global Acne Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Acne Medicine Sales Value Market Share by Country (2027-2032) Table 38. HUAPONT Company Information Table 39. HUAPONT Business Overview Table 40. HUAPONT Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. HUAPONT Acne Medicine Product Portfolio Table 42. HUAPONT Recent Development Table 43. Teva Company Information Table 44. Teva Business Overview Table 45. Teva Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Teva Acne Medicine Product Portfolio Table 47. Teva Recent Development Table 48. Sine Pharma Company Information Table 49. Sine Pharma Business Overview Table 50. Sine Pharma Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Sine Pharma Acne Medicine Product Portfolio Table 52. Sine Pharma Recent Development Table 53. Lion Company Information Table 54. Lion Business Overview Table 55. Lion Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Lion Acne Medicine Product Portfolio Table 57. Lion Recent Development Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Mylan Acne Medicine Product Portfolio Table 62. Mylan Recent Development Table 63. Sun Pharma Company Information Table 64. Sun Pharma Business Overview Table 65. Sun Pharma Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sun Pharma Acne Medicine Product Portfolio Table 67. Sun Pharma Recent Development Table 68. Mayne Pharma Company Information Table 69. Mayne Pharma Business Overview Table 70. Mayne Pharma Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Mayne Pharma Acne Medicine Product Portfolio Table 72. Mayne Pharma Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Acne Medicine Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Galderma Company Information Table 79. Galderma Business Overview Table 80. Galderma Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Galderma Acne Medicine Product Portfolio Table 82. Galderma Recent Development Table 83. Bausch Health Company Information Table 84. Bausch Health Business Overview Table 85. Bausch Health Acne Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bausch Health Acne Medicine Product Portfolio Table 87. Bausch Health Recent Development Table 88. Almirall Company Information Table 89. Almirall Business Overview Table 90. Almirall Acne Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Almirall Acne Medicine Product Portfolio Table 92. Almirall Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Acne Medicine Product Image Figure 2. Global Acne Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acne Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Acne Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. OTC Image Figure 8. Prescription Medicine Image Figure 9. Global Acne Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Acne Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Acne Medicine Sales Value Share by Type (2021-2032) Figure 12. Topical Image Figure 13. Oral Image Figure 14. Global Acne Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Acne Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Acne Medicine Sales Value Share by Application (2021-2032) Figure 17. Global Acne Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Acne Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Acne Medicine Sales Value (2021-2032) & (US$ Million) Figure 20. North America Acne Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Acne Medicine Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Acne Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Acne Medicine Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Acne Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Acne Medicine Sales Value (2021-2032) & (US$ Million) Figure 26. South America Acne Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Acne Medicine Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Acne Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Acne Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Acne Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Acne Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Prescription Medicine
Applications
  • Topical
  • Oral
Companies covered
  • HUAPONT
  • Teva
  • Sine Pharma
  • Lion
  • Mylan
  • Sun Pharma
  • Mayne Pharma
  • GlaxoSmithKline
  • Galderma
  • Bausch Health
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Acne Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Acne Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Acne Medicine Market Dynamics
  1. 2.1 Acne Medicine Industry Trends
  2. 2.2 Acne Medicine Industry Drivers
  3. 2.3 Acne Medicine Industry Opportunities and Challenges
  4. 2.4 Acne Medicine Industry Restraints
3 Acne Medicine Market by Company
  1. 3.1 Global Acne Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Acne Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Acne Medicine Company Ranking (2024-2026)
  4. 3.4 Global Acne Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global Acne Medicine Company Product Type and Application
  6. 3.6 Global Acne Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Acne Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Acne Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Acne Medicine Market by Type
  1. 4.1 Acne Medicine Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 Prescription Medicine
  4. 4.2 Global Acne Medicine Sales Value by Type
  5. 4.2.1 Global Acne Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Acne Medicine Sales Value by Type (2021-2032)
  7. 4.2.3 Global Acne Medicine Sales Value Share by Type (2021-2032)
5 Acne Medicine Market by Application
  1. 5.1 Acne Medicine Application Introduction
  2. 5.1.1 Topical
  3. 5.1.2 Oral
  4. 5.2 Global Acne Medicine Sales Value by Application
  5. 5.2.1 Global Acne Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Acne Medicine Sales Value by Application (2021-2032)
  7. 5.2.3 Global Acne Medicine Sales Value Share by Application (2021-2032)
6 Acne Medicine Regional Value Analysis
  1. 6.1 Global Acne Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acne Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Acne Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Acne Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Acne Medicine Sales Value (2021-2032)
  7. 6.3.2 North America Acne Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Acne Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe Acne Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Acne Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Acne Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Acne Medicine Sales Value (2021-2032)
  16. 6.6.2 South America Acne Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Acne Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Acne Medicine Sales Value Share by Country, 2025 VS 2032
7 Acne Medicine Country-level Value Analysis
  1. 7.1 Global Acne Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acne Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Acne Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Acne Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Acne Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Acne Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Acne Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Acne Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Acne Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Acne Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Acne Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Acne Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Acne Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Acne Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Acne Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Acne Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Acne Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Acne Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Acne Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Acne Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Acne Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Acne Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Acne Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Acne Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Acne Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Acne Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Acne Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Acne Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Acne Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Acne Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Acne Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Acne Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Acne Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Acne Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Acne Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Acne Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Acne Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Acne Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Acne Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Acne Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Acne Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Acne Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Acne Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Acne Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Acne Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Acne Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Acne Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Acne Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Acne Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Acne Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Acne Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Acne Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Acne Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Acne Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Acne Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Acne Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Acne Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Acne Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Acne Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Acne Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Acne Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Acne Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Acne Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Acne Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Acne Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Acne Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Acne Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Acne Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Acne Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Acne Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Acne Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Acne Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Acne Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Acne Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Acne Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Acne Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Acne Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Acne Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Acne Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Acne Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Acne Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Acne Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Acne Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Acne Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Acne Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Acne Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Acne Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Acne Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HUAPONT
  2. 8.1.1 HUAPONT Company Information
  3. 8.1.2 HUAPONT Business Overview
  4. 8.1.3 HUAPONT Acne Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HUAPONT Acne Medicine Product Portfolio
  6. 8.1.5 HUAPONT Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Acne Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Acne Medicine Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sine Pharma
  14. 8.3.1 Sine Pharma Company Information
  15. 8.3.2 Sine Pharma Business Overview
  16. 8.3.3 Sine Pharma Acne Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sine Pharma Acne Medicine Product Portfolio
  18. 8.3.5 Sine Pharma Recent Developments
  19. 8.4 Lion
  20. 8.4.1 Lion Company Information
  21. 8.4.2 Lion Business Overview
  22. 8.4.3 Lion Acne Medicine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lion Acne Medicine Product Portfolio
  24. 8.4.5 Lion Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Acne Medicine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Acne Medicine Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Sun Pharma
  32. 8.6.1 Sun Pharma Company Information
  33. 8.6.2 Sun Pharma Business Overview
  34. 8.6.3 Sun Pharma Acne Medicine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharma Acne Medicine Product Portfolio
  36. 8.6.5 Sun Pharma Recent Developments
  37. 8.7 Mayne Pharma
  38. 8.7.1 Mayne Pharma Company Information
  39. 8.7.2 Mayne Pharma Business Overview
  40. 8.7.3 Mayne Pharma Acne Medicine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mayne Pharma Acne Medicine Product Portfolio
  42. 8.7.5 Mayne Pharma Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Acne Medicine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Acne Medicine Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Galderma
  50. 8.9.1 Galderma Company Information
  51. 8.9.2 Galderma Business Overview
  52. 8.9.3 Galderma Acne Medicine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Galderma Acne Medicine Product Portfolio
  54. 8.9.5 Galderma Recent Developments
  55. 8.10 Bausch Health
  56. 8.10.1 Bausch Health Company Information
  57. 8.10.2 Bausch Health Business Overview
  58. 8.10.3 Bausch Health Acne Medicine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch Health Acne Medicine Product Portfolio
  60. 8.10.5 Bausch Health Recent Developments
  61. 8.11 Almirall
  62. 8.11.1 Almirall Company Information
  63. 8.11.2 Almirall Business Overview
  64. 8.11.3 Almirall Acne Medicine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Almirall Acne Medicine Product Portfolio
  66. 8.11.5 Almirall Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst